secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2022-12-29T23:59:59+00:00
Accession:  0001193125-22-314745
Event type: debt
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics Amends Loan Agreement with Oxford Finance, Adds Borrowers and Extends Interest-Only Period
--------------------------------------------------------------------------------

- Tempest Therapeutics entered into a First Amendment to Loan and Security Agreement with Oxford Finance LLC on Dec 23, 2022.
- The amendment adds Tempest Therapeutics and Millendo Therapeutics US as co-borrowers under the loan.
- Interest-only repayment period extended through Dec 31, 2023, with possible extension to June 30, 2024.
- Lender permitted a one-time prepayment of $5.0 million by Dec 28, 2022.
- Minimum liquidity covenant of $5.0 million in collateral accounts required.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312522314745/0001193125-22-314745-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312522314745/d411465d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-314745

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer